4,573 articles in this topic
A new in vivo therapy aims to reprogram macrophages inside the body using mRNA and lipid nanoparticles, potentially replacing complex cell transplants.
Over 3,000 carriers of the top Alzheimer's risk gene will track lifestyle and cognition for years in a landmark real-world study.
REP-0003 targets toxic intracellular cholesterol in artery walls — a rare disease breakthrough with wide cardiovascular aging implications.
A new review identifies PRMT enzymes as master regulators linking mitochondrial stress to sarcopenia and neuromuscular decline.
Psychological stress impairs hematopoietic stem cells by suppressing brain regions, depleting gut microbiome-derived spermidine, and triggering ferroptosis.
Researchers mapped the molecular architecture of aging to identify existing drugs that could be repurposed to extend healthy lifespan.
The NXTSTIM EcoAI platform combines TENS, EMS, and machine learning to personalize electrostimulation therapy for chronic pain in real time.
A multidisciplinary review reveals EMS may benefit cognitive disorders, metabolic disease, and pain—not just muscle rehab.
A landmark review identifies 16 objective measures for cancer-related fatigue, moving beyond subjective scales to real physiological data.
A landmark 2025 review maps how gut bacteria alter DNA methylation, histone marks, and RNA modifications to drive IBD and colorectal cancer.
New review links specific gut bacteria imbalances to Long COVID symptoms and shows probiotics, prebiotics, and FMT can help.
A landmark 2026 review reveals how gut bacteria shape cancer risk, drug metabolism, and immunotherapy response — and how to harness them therapeutically.
